Literature DB >> 4745331

Letter: Co-trimoxazole in bubonic plague.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4745331      PMCID： PMC1587212          DOI： 10.1136/bmj.4.5884.108-c

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Plague--clinical features and management.

Authors:  S K Kabra; Y Jain; V Seth
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

2.  Antibiotic treatment of experimental pneumonic plague in mice.

Authors:  W R Byrne; S L Welkos; M L Pitt; K J Davis; R P Brueckner; J W Ezzell; G O Nelson; J R Vaccaro; L C Battersby; A M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

4.  Factors Influencing Atypical Clinical Presentations during the 2017 Madagascar Pneumonic Plague Outbreak: A Prospective Cohort Study.

Authors:  Alex P Salam; Mihaja Raberahona; Prisca Andriantsalama; Liam Read; Faraniaina Andrianarintsiferantsoa; Tiana Razafinambinintsoa; Rado Rakotomalala; Rodrigue N E Hasiniatsy; Dominique Razafimandimby; Lyndsey Castle; Anna Funk; Reziky T Mangahasimbola; Bertrand Renaud; Eric Bertherat; Andrew Lovering; Jean-Michel Heraud; Voahangy Andrianaivoarimanana; Randrianirina Frédérique; Norosoa Razanajatovo; Laurence Baril; Arnaud Fontanet; Minoarisoa Rajerison; Peter Horby; Mamy Randria; Rindra Randremanana
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.